Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease [2]

Annals of Oncology

Volumn 16, Issue 3, 2005, Pages 514-515

  Garipidou, V ^a   Vakalopoulou, S ^a   Zafiriadou, E ^b   Tziomalos, K ^a   Perifanis, V ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BLEOMYCIN; CHLORAMBUCIL; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; TUBERCULOSTATIC AGENT; VINBLASTINE; VINCRISTINE;

ADULT; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LETTER; LUNG INFILTRATE; LUNG LAVAGE; LUNG TOXICITY; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK ASSESSMENT; TRANSBRONCHIAL BIOPSY;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; INFLAMMATION; LUNG DISEASES; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; VINBLASTINE;

EID: 16244398891     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi073     Document Type: Letter

References (5)

1. Jules-Elysee K, White DA. Bleomycin-induced pulmonary toxicity. Clin Chest Med 1990; 11: 1-20.
2. Onuma T, Holland JF, Masuda H et al. Microbiological assay of bleomycin: inactivation, fissure distribution, and clearance. Cancer 1974; 33: 1230-1238.
3. Harrison JH Jr, Hoyt DG, Lazo JS. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol Pharmacol 1989; 36: 231-238.
4. Sleijfer S. Bleomycin-induced pneumonitis. Chest 2001; 120: 617-624.
5. Rossi SE, Erasmus JJ, McAdams HP et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20: 1245-1259.